Infection mechanism of Rift Valley fever virus identified

November 10, 2017, Institut Pasteur
Model of the Rift Valley virus fusion protein interacting with a cell membrane (in white and green), obtained using molecular dynamics. The enlargement shows the lipid head 'recognition pocket', with the protein represented at the surface. Credit: Pablo Guardado-Calvo, Institut Pasteur

Rift Valley fever virus, transmitted by mosquitoes, is responsible for outbreaks in livestock in Africa and can also be fatal in humans. Scientists from the Institut Pasteur and the CNRS, working with the University of Göttingen, have characterized the mechanism used by the virus to insert one of its envelope proteins into the host cell membrane, thereby enabling it to infect the cell. They have demonstrated that the viral envelope protein has a "pocket" that specifically recognizes a category of lipids in the cell membrane. This pocket is also found in other human pathogenic viruses transmitted by different mosquitoes, such as the Zika and chikungunya viruses. Understanding these interactions should pave the way for the identification of new therapeutic strategies that target viruses transmitted by these mosquitoes.

The findings were published in the journal Science on November 3, 2017.

Rift Valley fever (RVF) virus is a bunyavirus that was first isolated from sheep in Kenya in 1930. The spread of RVF has serious economic consequences in Africa. The virus also causes severe disease in humans who come into contact with contaminated animals or who are bitten by infected , resulting in severe encephalitis and hemorrhagic fever that can prove fatal. RVF therefore also represents a significant public health threat. In 2000, the virus spread outside the African continent to Saudi Arabia and Yemen. There are concerns that it may also extend to Asia and Europe.

RVF virus spreads in its host by fusing with cell membranes so that it can proliferate and infect other cells. Scientists in the Structural Virology Unit (Institut Pasteur/CNRS) directed by Félix Rey, in collaboration with the University of Göttingen, characterized the mechanism used by the virus to insert one of its surface proteins into the host cell and drive fusion. They also determined the atomic structure of this new -lipid complex, demonstrating that this protein has a "pocket" which specifically recognizes the hydrophilic heads of some of the lipids that make up the cell membrane. Importantly, this "recognition pocket" is found not only in RVF but also in the envelope proteins of other viral families transmitted by arthropods, such as the dengue, Zika and chikungunya viruses, which have caused major worldwide epidemics in recent years. In the homologous protein of the , the scientists pinpointed one of the residues of the recognition pocket as amino acid 226. In 2006, the A226V mutation enabled chikungunya to be transmitted by a new species of mosquito that is prevalent on Reunion Island (Aedes albopictus, or the tiger mosquito).

"This study offers a further illustration of the power of comparative analyses of viruses that appear very distant, such as bunyaviruses, alphaviruses and flaviviruses, which can result in highly significant findings and reveal shared mechanisms of action," said Félix Rey, head of the Structural Virology Unit (Institut Pasteur/CNRS), where the study was carried out.

Understanding the mechanism used by these viruses for insertion in the paves the way for the development of therapeutic agents that target the "pocket" involved in the fusion of viral and cell membranes with the aim of preventing pathogenic arboviruses from entering host .

Explore further: Millions of infected Brazilian mosquitoes to tackle dengue

More information: P. Guardado-Calvo et al, A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion, Science (2017). DOI: 10.1126/science.aal2712

Related Stories

Millions of infected Brazilian mosquitoes to tackle dengue

August 30, 2017
Brazilian scientists on Tuesday began to unleash the first of millions of mosquitoes infected with a bacteria meant to prevent the insects from transmitting the dengue virus to humans.

Research reveals how antibodies neutralize mosquito-borne virus

April 2, 2013
Researchers have learned the precise structure of the mosquito-transmitted chikungunya virus pathogen while it is bound to antibodies, showing how the infection is likely neutralized.

Mosquitoes that spread Zika virus could simultaneously transmit other viruses

May 19, 2017
A new study led by Colorado State University researchers found that Aedes aegypti, the primary mosquito that carries Zika virus, might also transmit chikungunya and dengue viruses with one bite. The findings shed new light ...

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.